A clinic explainer sorting the brand names, Ozempic and Wegovy versus Mounjaro and Zepbound, and how each drug works.
Recap by typeshit. Post by @anzarahealth on Instagram.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A new review in Cureus pulls together efficacy and safety evidence on orforglipron, the daily pill alternative to injectable GLP-1 drugs.
Clinical trials point to GLP-1 drugs possibly helping with alcohol, opioid and nicotine addiction by changing how the brain responds, per U.S. News.
Loading…